Study recruitment: Exploring the link between type 2 diabetes and pancreatic cancer

A statement from the researchers said: “The aim of the SAFE-D research study is to evaluate a novel blood test, the Avantect test, to detect clues or biomarkers for the presence of pancreatic cancer in people that have been newly diagnosed with type II diabetes.  

“According to the 2021 National Diabetes Audit, about 240,000 patients are diagnosed with diabetes every year in England. Unfortunately, it is known that this particular group of people have up to ten times higher-than-average risk of developing pancreatic cancer. Pancreatic cancer is a cancer that is currently very hard to diagnose in its early stages making it harder to treat successfully. However, if diagnosed early enough, it is possible to prolong survival by removing the cancer with surgery.

“There is currently no approved screening test for pancreatic cancer.

“The SAFE-D study aims to improve early pancreatic cancer detection to improve patient survival and save lives.”

For more information about the study click here

To volunteer to participate contact the study team by email or by telephone 023 8231 8756

Read more about type 2 diabetes

NOTE: DRWF will from time-to-time advise readers of ‘calls to participate’ in diabetes and related health research studies. It should not necessarily be considered that the charity is in any way connected to the study or the group issuing the call for participants. If we are involved in any way, we will make this known. We will only share external calls where we have confirmed that the study holds ethics committee approval, and the study is specific to diabetes and related health. Taking part in a medical research study is a big step and further helpful information can be found via the National Institute for Health and Care Research Clinical Trials Guide.